Magenta Therapeutics to Present at the J.P. Morgan Healthcare Conference and the B. Riley Virtual Oncology Conference

Rhea-AI Summary

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology firm, will participate in two virtual investor conferences in January 2022. The company will present at the 40th Annual J.P. Morgan Healthcare Conference on January 13 at 9:45 a.m. ET, followed by a Q&A session. Additionally, Magenta will be at the B. Riley Virtual Oncology Conference on January 28 at 11:00 a.m. ET. Webcasts for both presentations will be available on their website, with replays accessible for 30 days. Magenta aims to enhance stem cell transplant accessibility for patients with various diseases.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in the following January investor conferences:

• 40th Annual J.P. Morgan Healthcare Conference, to be held virtually, on Thursday, January 13^th, 2022, at 9:45 a.m. ET, immediately followed by a Q&A session
• B. Riley Virtual Oncology Conference, on Friday, January 28^th, 2022, at 11:00 a.m. ET

A live webcast of the presentations can be accessed through the Investors & Media section of Magenta’s website at https://investor.magentatx.com/events-and-presentations. A replay of each webcast will be available on Magenta’s website for 30 days following the events.

About Magenta Therapeutics
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Massachusetts. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220105005293/en/

Leah Monteiro

Magenta Therapeutics

Vice President, Investor Relations

lmonteiro@magentatx.com

Source: Magenta Therapeutics

FAQ

What investor conferences will Magenta Therapeutics (MGTA) attend in January 2022?

Magenta Therapeutics will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 13, 2022, and the B. Riley Virtual Oncology Conference on January 28, 2022.

What time will Magenta Therapeutics present at the J.P. Morgan Healthcare Conference?

Magenta Therapeutics will present at the J.P. Morgan Healthcare Conference on January 13, 2022, at 9:45 a.m. ET.

How can I access the webcasts of Magenta Therapeutics' presentations?

Live webcasts of Magenta Therapeutics' presentations can be accessed through the Investors & Media section of their website, with replays available for 30 days.

What is the focus of Magenta Therapeutics' research?

Magenta Therapeutics is focused on developing medicines to enhance the curative power of stem cell transplants for patients with blood cancers, genetic diseases, and autoimmune diseases.